المؤلفون: Milo Gatti, Matteo Rinaldi, Linda Bussini, Cecilia Bonazzetti, Renato Pascale, Zeno Pasquini, Francesca Faní, Mariana Nunes Pinho Guedes, Anna Maria Azzini, Elena Carrara, Zaira R. Palacios-Baena, Giulia Caponcello, Eduardo Reyna-Villasmil, Evelina Tacconelli, Jesús Rodríguez-Baño, Pierluigi Viale, Maddalena Giannella, Natascia Caroccia, Federica Arbizzani, Maria Eugenia Giacomini, Oana Vatamanu, Elisa Razzaboni, Maria Elena De Rui, Anna Gorska, Natalia Maldonado, Paula Olivares, David Gutiérrez-Campos, Ana Belén Martín-Gutiérrez, Virginia Palomo, Almudena Serna

المساهمون: Gatti, Milo, Rinaldi, Matteo, Bussini, Linda, Bonazzetti, Cecilia, Pascale, Renato, Pasquini, Zeno, Faní, Francesca, Pinho Guedes, Mariana Nune, Azzini, Anna Maria, Carrara, Elena, Palacios-Baena, Zaira R, Caponcello, Giulia, Reyna-Villasmil, Eduardo, Tacconelli, Evelina, Rodríguez-Baño, Jesú, Viale, Pierluigi, Giannella, Maddalena

المصدر: Clinical Microbiology and Infection. 28:1057-1065

مصطلحات موضوعية: Microbiology (medical), Solid organ transplant recipients, Clinical outcome, Solid organ transplant recipient, COVID-19, Organ Transplantation, General Medicine, 30-Day mortality rate, Superinfections, Transplant Recipients, Infectious Diseases, Humans, Prospective Studies, Retrospective Studies

وصف الملف: application/pdf; ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b94bfa93e046b0e795edc53a1f9d5afTest
https://doi.org/10.1016/j.cmi.2022.02.039Test

المؤلفون: Xin-Ying Ji, Muhammad Farhan Khan, Asim Ur Rehman, Mahnoor Baloch, Lei Qian, Dongdong Wu, Ebenezeri Erasto Ngowi, Nazeer Hussain Khan, Maria Mir

المصدر: Journal of Advanced Research, Vol 36, Iss, Pp 223-247 (2022)
Journal of Advanced Research

مصطلحات موضوعية: 0301 basic medicine, Medicine (General), Skin Neoplasms, Science (General), Polymers, Mn, Manganese, MSC, Melanoma skin cancer, PLA-HPG, Poly (d-l-lactic acid)-hyperbranched polyglycerol, Pharmaceutical Science, PATCH1, Patch, SCC, Squamous cell Carcinoma, PCL, Poly (ε-caprolactone), Disease, 5-ALA, 5-aminolevulinic acid, PLL, Poly (L-lysine), Polyethylene Glycols, Q1-390, Drug Delivery Systems, hTERT, Human telomerase reverse transcriptase, 0302 clinical medicine, Polymeric nanocarriers, Squamous cell carcinoma, UV, Ultra Violet, Gene delivery, PDT, Photodynamic therapy, PLGA, Poly (lactide-co-glycolide) copolymers, media_common, Multidisciplinary, Melanoma, GNR-PEG-MN, PEGylated gold nanorod microneedle, CREB, response element-binding protein, SC, Skin cancer, PEG, Polyethylene glycol, IPM, Isopropyl myristate, 030220 oncology & carcinogenesis, HPMC, Hydroxypropyl methylcellulose, Drug delivery, NMSC, Non melanoma skin cancer, BCC, Basal cell carcinoma, MNPs, Magnetic nanoparticle, dPG, Dendritic polyglycerol, cAMP, Cyclic adenosine monophosphate, Microneedles, Drug, medicine.medical_specialty, BCCs, Basal cell carcinomas, SPIO, Superparamagnetic iron oxide, media_common.quotation_subject, NPs, Nano Particles, MRI, Magnetic Resonance Imaging, DDS, Drug delivery system, MNs, Microneedles, 03 medical and health sciences, R5-920, medicine, Humans, SMO, Smoothen, Intensive care medicine, Biology, AIDS, Acquired immune deficiency syndrome, ComputingMethodologies_COMPUTERGRAPHICS, PLA, Poly lactic acid, PAMAM, Poly-amidoamines, Cancer, HH, Hedgehog, DIM-D, Di indolyl methane derivative, medicine.disease, Nanostructures, Gd, Gadolinium, 030104 developmental biology, MCIR, Melanocortin-1 receptor, Basal cell carcinoma, PAN, Polyacrylonitrile, 5-FU, 5-fluorouracil, Skin cancer, OTR, Organ transplant recipients, QDs, Quantum dots

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4504efcb0df22ab6d14aa8271e9a2d16Test
https://doi.org/10.1016/j.jare.2021.06.014Test

المؤلفون: Reem S. Almaghrabi, Fatimah S. Alhamlan, Ashraf Dada, Jaffar A. Al-Tawfiq, Mohammad K. Al Hroub, Mohammed F. Saeedi, Maha Alamri, Bushra Alhothaly, Abdulmohsin Alqasabi, Ahmed A. Al-Qahtani, Awad Al-Omari, Abeer N. Alshukairi

المصدر: Journal of Infection and Public Health, Vol 15, Iss 1, Pp 51-55 (2022)
Journal of Infection and Public Health

مصطلحات موضوعية: COVID-19 Vaccines, Solid organ transplant recipients, SARS-CoV-2, SARSCoV-2 variant of concern, Public Health, Environmental and Occupational Health, COVID-19, Vaccine Efficacy, Organ Transplantation, Infectious and parasitic diseases, RC109-216, General Medicine, Article, Breakthrough infection, Infectious Diseases, Humans, Public aspects of medicine, RA1-1270, BNT162 Vaccine, Outcome

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff93aa25f16e0dee38a06e77415574e9Test
https://doi.org/10.1016/j.jiph.2021.11.021Test

المؤلفون: A. V. Nikulin, I. V. Pashkov, Ya. S. Yakunin

المصدر: Vestnik Transplantologii i Iskusstvennyh Organov, Vol 23, Iss 4, Pp 19-25 (2022)

مصطلحات موضوعية: lung cancer, Transplantation, RD1-811, immunosuppressive therapy, Immunology and Allergy, Surgery, solid organ transplant recipients, respiratory system, malignant tumors

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2e587008e4fe76289a2e3496f4396d6Test
https://doi.org/10.15825/25/1995-1191-2021-4-19-25Test

المؤلفون: Rosalia Busà, Giovanna Russelli, Monica Miele, Maria Concetta Sorrentino, Mariangela Di Bella, Francesca Timoneri, Giuseppina Di Mento, Alessandra Mularoni, Patrizio Vitulo, Pier Giulio Conaldi, Matteo Bulati

المصدر: Viruses; Volume 14; Issue 10; Pages: 2299

مصطلحات موضوعية: Infectious Diseases, mRNA vaccine, solid organ transplant recipients, immune response, IgG, IgA, T-cell response, SARS-CoV-2, COVID-19, booster, fourth dose, COVID-19 Vaccines, Virology, Immunoglobulin G, Immunity, Humans, Organ Transplantation, Antibodies, Viral, Transplant Recipients, Immunoglobulin A

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a799ab0a4b299e8024871fbbe8b60543Test
https://pubmed.ncbi.nlm.nih.gov/36298854Test

المؤلفون: Liliane Borik-Heil, Georg Endler, Walther Parson, Andreas Zuckermann, Lisa Schnaller, Keziban Uyanik-Ünal, Peter Jaksch, Georg Böhmig, Daniel Cejka, Katharina Staufer, Elisabeth Hielle-Wittmann, Susanne Rasoul-Rockenschaub, Peter Wolf, Raute Sunder-Plassmann, Alexandra Geusau

المصدر: Cancers
Volume 15
Issue 3
Pages: 864

مصطلحات موضوعية: Cancer Research, immunosuppression, Oncology, keratinocyte cancer, solid organ transplant recipients, MC1R, UV burden, skin aging

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::387d4e1cd986a52e8e8bae6086836962Test
https://doi.org/10.3390/cancers15030864Test

المؤلفون: Roman V. Ishenko, Sergei V. Golovincki, Artur R. Akhmedianov, Sergei E. Voskanyan, Ilya Yu. Kolyshev

المصدر: Клиническая практика, Vol 11, Iss 2, Pp 101-106 (2020)

مصطلحات موضوعية: Hepatitis, medicine.medical_specialty, Cirrhosis, business.industry, medicine.disease, medicine.disease_cause, Gastroenterology, Organ transplantation, Transplantation, sars-cov-2, liver transplant, covid-19, Respiratory failure, Infectious disease (medical specialty), Hepatocellular carcinoma, Internal medicine, medicine, Medicine, business, organ transplant recipients, Coronavirus

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86eb08bdd28cf9c5ebcd47997a5c6953Test
https://doi.org/10.17816/clinpract35121Test

المؤلفون: Smaragdi Marinaki, Dimitrios Degiannis, Sotirios Roussos, Efstathios Xagas, Paraskevi Tsoutsoura, Stamatis Adamopoulos, Vana Sypsa, Antigoni Chaidaroglou, Ioanna D. Pavlopoulou, Angelos Hatzakis, Ioannis N. Boletis

المصدر: Vaccines; Volume 10; Issue 2; Pages: 190

مصطلحات موضوعية: Pharmacology, Infectious Diseases, Drug Discovery, Immunology, Pharmacology (medical), SARS-CοV-2 vaccination, clinical transplantation, mRNA vaccines, solid organ transplant recipients

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b19236067a11e7e5e2bd58633a0fa5aTest
https://pubmed.ncbi.nlm.nih.gov/35214649Test

المؤلفون: Orly Efros, Roi Anteby, Mirit Halfon, Eshcar Meisel, Eyal Klang, Shelly Soffer

المصدر: Vaccines
Vaccines, Vol 10, Iss 95, p 95 (2022)
Vaccines; Volume 10; Issue 1; Pages: 95

مصطلحات موضوعية: Pharmacology, Infectious Diseases, COVID-19, vaccines, third dose, solid organ transplant recipients, Drug Discovery, Immunology, Medicine, Pharmacology (medical), Article

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d34c6ec5634a8ce992406f93b0db769Test
https://pubmed.ncbi.nlm.nih.gov/35062756Test

المؤلفون: Stratigos, Alexander J, Garbe, Claus, Dessinioti, Clio, Lebbe, Celeste, Bataille, Veronique, Bastholt, Lars, Dreno, Brigitte, Fargnoli, Maria Concetta, Forsea, Ana Maria, Frenard, Cecille, Harwood, Catherine Α, Hauschild, Axel, Hoeller, Christoph, Kandolf-Sekulovic, Lidija, Kaufmann, R, Kelleners-Smeets, Nicole Wj, Malvehy, Josep, Del Marmol, Veronique, Middleton, Mark R, Moreno-Ramirez, David, Pellecani, Giovanni, Peris, Ketty, Saiag, Philippe, van den Beuken-van Everdingen, Marieke H J, Vieira, Ricardo, Zalaudek, Iris, Eggermont, Alexander M M, Grob, Jean-Jacques, European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO) and the European Organization for Research and Treatment of Cancer (EORTC)

المساهمون: National and Kapodistrian University of Athens (NKUA), Eberhard Karls Universität Tübingen = Eberhard Karls University of Tuebingen, Immunologie humaine, physiopathologie & immunothérapie (HIPI (UMR_S_976 / U976)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), North & East Hertfordshire NHS Trust [Northwood, UK], Odense University Hospital (OUH), Centre de Recherche en Cancérologie et Immunologie Nantes-Angers (CRCINA), Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes), Centre d’Investigation Clinique de Nantes (CIC Nantes), Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre hospitalier universitaire de Nantes (CHU Nantes), University of L'Aquila [Italy] (UNIVAQ), University of Medicine and Pharmacy 'Carol Davila' Bucharest (UMPCD), Queen Mary University of London (QMUL), Kiel University, Medizinische Universität Wien = Medical University of Vienna, Military Medical Academy [Belgrade, Serbia] (2MA), Frankfurt University Hospital, Maastricht University Medical Centre (MUMC), Maastricht University [Maastricht], University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona (UB), CIBER de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III [Madrid] (ISC), Université libre de Bruxelles (ULB), Hôpital Erasme [Bruxelles], University of Oxford, Hospital Universitario Virgen Macarena [Sevilla, Spain] (HUVM), University - Hospital of Modena and Reggio Emilia [Modena, Italy], Università cattolica del Sacro Cuore = Catholic University of the Sacred Heart [Roma] (Unicatt), Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Istituto Neurologico Mediterraneo (NEUROMED I.R.C.C.S.), Università degli Studi di Roma 'La Sapienza' = Sapienza University [Rome] (UNIROMA)-University of Naples Federico II = Università degli studi di Napoli Federico II, Biomarqueurs et essais cliniques en Cancérologie et Onco-Hématologie (BECCOH), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Saclay, Hôpital Ambroise Paré [AP-HP], University Veterinary Hospital [Coimbra, Portugal], Università degli studi di Trieste = University of Trieste, Princess Máxima Center for Pediatric Oncology, Assistance Publique - Hôpitaux de Marseille (APHM), Aix Marseille Université (AMU), Novartis Les Laboratories Pierre Fabre Sanofi Bristol-Myers Squibb, BMS Pfizer Amgen Roche LEO Pharma Research Foundation Cilag Merck Meso Scale Diagnostics, MSD Genentech, The guidelines were supported by grants from the EADO for the guideline meetings. The authors did this work on a voluntary basis and did not receive any honorarium or reimbursements. Guidelines development group members stated their conflicts of interest in the relevant section., Dr. Stratigos reports personal fees and/or research support from Novartis , Roche , BMS , Abbvie , Sanofi , Regeneron , Genesis Pharma , outside the submitted work. Dr. Garbe reports personal fees from Amgen , personal fees from MSD , grants and personal fees from Novartis , grants and personal fees from NeraCare, grants and personal fees from BMS , personal fees from Pierre Fabre , personal fees from Philogen, grants and personal fees from Roche , grants and personal fees from Sanofi , outside the submitted work. Dr. Dessinioti has nothing to disclose. Dr. Lebbe reports grants and personal fees from Bristol-Myers Squibb , personal fees from MSD , personal fees from Novartis , personal fees from Amgen , grants and personal fees from Roche , personal fees from Avantis Medical Systems, personal fees from Pierre Fabre , personal fees from Pfizer , personal fees from Incyte, outside the submitted work. Dr. Bataille reports personal fees from Novartis , personal fees from Merck MSD , outside the submitted work. Dr. Bastholt reports personal fees for advisory board activity: BMS , Roche , Novartis , Pierre-Fabre, Astra Zeneca, InCyte, MSD / Merck , Bayer . Dr. Dréno reports grants and personal fees from BMS , personal fees from MSD , grants and personal fees from Roche , grants and personal fees from Fabre, grants and personal fees from Sanofi , outside the submitted work. Dr. Fargnoli reports grants and personal fees from Almirall, grants and personal fees from Leo Pharma, personal fees from Janssen, grants and personal fees from Novartis , personal fees from Lilly , grants and personal fees from Sanofi , personal fees from UCB , grants and personal fees from Abbvie , personal fees from Celgene , personal fees from Pierre Fabre , grants and personal fees from Galderma , personal fees from Mylan, personal fees from Medac Pharma, personal fees from Roche , personal fees from Sun Pharma , outside the submitted work. Dr. Forsea reports scientific consultant/speaker fee from Novartis , Leo Pharma, Solartium, Pierre-Fabre, outside the submitted work. Dr. Frenard has nothing to disclose. Dr. Harwood reports institutional research grants and honoraria from Sanofi , Novartis , Merck , Pfizer , Galderma , MEDA, Almirall, Pellepharm, Leo Pharma, CERIES. Dr. Hauschild reports honoraria and/or research grants from: Almirall, BMS , Roche , Novartis , Pierre-Fabre, Sunpharma, MerckSerono, SanofiAventis, Regeneron , MSD / Merck , Philogen, OncoSec outside the submitted work. Dr. Hoeller reports grants and personal fees from Amgen , personal fees from BMS , personal fees from MSD , personal fees from Novartis , personal fees from Pierre Fabre , personal fees from Roche , personal fees from Sanofi , personal fees from Incyte, outside the submitted work. Dr. Kandolf-Sekulovic reports speakers’ honoraria for Roche, Novartis, MSD, BMS, Janssen outside the submitted work. Dr. Kaufmann reports institutional research grants (clinical trials) from: AbbVie , Amgen , Biontech, BMS , Celgene , Galderma , Janssen, Leo, Lilly , Merck , MSD , Novartis , Pierre Fabre , Pfizer , Regeneron , Roche , Wyeth . Advisory Board and Honoraria from Merz, Roche, Novartis. Dr. Kelleners-Smeets reports grants from Netherlands Organization for Health Research and Development, other from Janssen-Cilag, other from AbbVie , other from Galderma , outside the submitted work. Dr. Malvehy reports research grants from Almirall, ISDIN, Leo Pharma, Galderma , GSK , Cantabria, participation in advisory board meetings for Almirall, Sunpharma, BMS , Roche , Novartis , Pierre-Fabre. Dr. del Marmol reports personal fees from MSD , from BMS , personal fees from Sanofi , grants and personal fees from ABVIE, grants from Jansen, outside the submitted work. Dr. Middleton reports personal fees and/or grants from Amgen , Roche , Astrazeneca, GSK , Novartis , Immunocore, BMS , Eisai and Merck . Institutional funding from Millennium, Vertex, Pfizer , Regeneron , TCBiopharma, BiolineRx, Replimune, outside the submitted work. Dr. Moreno-Ramírez has nothing to disclose. Dr. Pellecani reports grants from university of modena and reggio emilia, during the conduct of the study, grants from novartis, grants and personal fees from almirall, grants from leo pharma, from null, outside the submitted work. Dr. Peris reports honoraria for advisory board and grants from AbbVie , Almirall, Biogen Celgene , Lilly , Galderma , Leo Pharma, Novartis , Roche , Sanofi , Sun Pharma , Sandoz outside the submitted work. Dr. Saiag reports honoraria for advisory board and grants from Amgen , Bristol-Myers Squibb , MSD , Merck-Serono, Novartis , Pfizer , Roche- Genentech , Pierre Fabre , and Sanofi , outside the submitted work. Dr. van den Beuken-van Everdingen has nothing to disclose. Dr. Vieira has nothing to disclose. Dr. Zalaudek reports honoraria and advisory board and grants from Sanofi , Sun Pharma , Novartis , Galderma , Roche , Celgene , Almirall, Leofarma, Mylan, Difa Cooper, Cieffe Labs, La Roche Posay, Pierre Fabre . Dr. Eggermont reports over the last 5 years personal fees as a consultant advisor for Biocad, BioInvent, Bristol Myers Squibb ( BMS ), CatalYm, Ellipses, Glaxo Smith Kline ( GSK ), HalioDX, Incyte, IO Biotech, ISA Pharmaceuticals, Merck Sharpe & Dohme ( MSD ), Novartis , Pfizer , Polynoma, Regeneron , Sanofi , Sellas, SkylineDx. Dr. Grob reports personal fees for advisory board and as speaker from Amgen , Roche , GSK , Novartis , BMS , Pierre fabre, Merck , Sanofi , Merck , Pfizer outside the submitted work., European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO) and the European Organization for Research and Treatment of Cancer (EORTC), HAL UVSQ, Équipe, Dermatologie, MUMC+: MA Dermatologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, RS: MHeNs - R3 - Neuroscience, MUMC+: TPZ Palliatieve Zorg (9), Stratigos, A. J., Garbe, C., Dessinioti, C., Lebbe, C., Bataille, V., Bastholt, L., Dreno, B., Fargnoli, M. C., Forsea, A. M., Frenard, C., Harwood, C. Alpha., Hauschild, A., Hoeller, C., Kandolf-Sekulovic, L., Kaufmann, R., Kelleners-Smeets, N. W., Malvehy, J., del Marmol, V., Middleton, M. R., Moreno-Ramirez, D., Pellecani, G., Peris, K., Saiag, P., van den Beuken-van Everdingen, M. H. J., Vieira, R., Zalaudek, I., Eggermont, A. M. M., Grob, J. -J., Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Paris (UP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA)

المصدر: European Journal of Cancer
European Journal of Cancer, 2020, 128, pp.60-82. ⟨10.1016/j.ejca.2020.01.007⟩
European Journal of Cancer, 128, 60-82. ELSEVIER SCI LTD
European journal of cancer, 128
European Journal of Cancer, Elsevier, 2020, 128, pp.60-82. ⟨10.1016/j.ejca.2020.01.007⟩
European Dermatology Forum (EDF), European Association of Dermato-Oncology (EADO), European Organization for Research and Treatment of Cancer (EORTC) 2020, ' European interdisciplinary guideline on invasive squamous cell carcinoma of the skin : Part 1. epidemiology, diagnostics and prevention ', European Journal of Cancer, vol. 128, pp. 60-82 . https://doi.org/10.1016/j.ejca.2020.01.007Test

مصطلحات موضوعية: 0301 basic medicine, Cancer Research, Skin Neoplasms, Staging, Medical Oncology, Palpation, Imaging, Low-risk, 0302 clinical medicine, Protective Clothing, Metastatic cSCC, Positron Emission Tomography Computed Tomography, Diagnosis, Epidemiology, Societies, Medical, AMERICAN JOINT COMMITTEE, Skin, Ultrasonography, Invasive cutaneous squamous cell carcinoma, medicine.diagnostic_test, NONSTEROIDAL ANTIINFLAMMATORY DRUGS, High-risk common primary cSCC, RANDOMIZED CONTROLLED-TRIAL, Prognosis, Magnetic Resonance Imaging, 3. Good health, LYMPH-NODE BIOPSY, Oncology, 030220 oncology & carcinogenesis, Carcinoma, Squamous Cell, Sunlight, Settore MED/35 - MALATTIE CUTANEE E VENEREE, Diagnosi, medicine.medical_specialty, Consensus, Prognosi, Sentinel lymph node, Locally advanced Cscc, Prevention, Dermatology, Humans, Lymph Nodes, Neoplasm Staging, Patient Education as Topic, Risk Assessment, Sunscreening Agents, [SDV.CAN]Life Sciences [q-bio]/Cancer, Physical examination, PERINEURAL INVASION, 03 medical and health sciences, BASAL-CELL, [SDV.CAN] Life Sciences [q-bio]/Cancer, Medical, Biopsy, medicine, CANCER PREVENTION, ORGAN TRANSPLANT RECIPIENTS, business.industry, Carcinoma, Cancer, Magnetic resonance imaging, Guideline, medicine.disease, Cancérologie, HIGH-RISK, 030104 developmental biology, Squamous Cell, SUN PROTECTION, Societies, business

وصف الملف: 1 full-text file(s): application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73017e8d64a0e3566ed10f8a2e527badTest
https://doi.org/10.1016/j.ejca.2020.01.007Test